cancer treatment

Advertisement
Patrick DalyOncology | August 23, 2022
Researchers analyzed recent studies on programmed cell death 1 (PD-1) and programmed death ligand-1 (PD-L1) to ...
Read More
Rebecca AraujoOncology | November 23, 2021
Chemotherapy agents may be triggering muscle loss in people with cancer starting at lower doses than previously ...
Kaitlyn D’OnofrioCOVID-19 | April 6, 2023
Delays and interruptions in cancer care as a result of the COVID-19 pandemic affected many patients, according to a ...
Rebecca AraujoPancreatic Cancer | August 22, 2023
The presence of systemic inflammation in patients with advanced pancreatic cancer may point to possible resistance to ...
Rebecca AraujoOncology | March 31, 2023
An analysis of patients with multiple myeloma (MM) who underwent autologous hematopoietic cell transplant (AHCT) showed ...
Rebecca AraujoOncology | March 31, 2023
Most Women Are Satisfied ‘Going Flat’ After Mastectomy, But Surgeons May Not Be Supportive of Decision ...
Rebecca AraujoOncology | April 23, 2023
Inflammation due to treatment with androgen deprivation therapy (ADT) may be the cause of increased fatigue in patients ...
Kaitlyn D’OnofrioOncology | September 22, 2023
Time-to-treatment initiation (TTI) may have an impact on survival in patients with certain common cancers, according to ...
Rebecca AraujoBreast Cancer | June 30, 2023
According to a new study, physicians failed to recognize side effects from radiation therapy in more than half of ...
Rebecca AraujoOncology | December 10, 2020
Prostate cancer surgery for patients with high-risk disease can be safely delayed up to six months following diagnosis, ...
Rebecca AraujoNon-Small Cell Lung Cancer | September 21, 2023
Janssen Pharmaceuticals has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...
Rebecca AraujoPancreatic Cancer | August 22, 2023
In a real-world study, dose reductions (DRs) of an FDA-approved therapy for pancreatic cancer were effective and ...
Kaitlyn D’OnofrioOncology | June 30, 2023
Cancer treatment is not a one-size-fits-all approach. Different types of cancer may be better treated with one ...
Rebecca AraujoPancreatic Cancer | August 22, 2023
A protein in the brain involved in the development of neurons, called Netrin-G1 (NetG1), may also impact the development ...
Rebecca AraujoOncology | November 20, 2020
Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy ...
Rebecca AraujoNon-Small Cell Lung Cancer | September 21, 2023
Early treatment with the anaplastic lymphoma kinase (ALK)-inhibitor lorlatinib reduced cancer progression and death in ...
Kaitlyn D’OnofrioOncology | November 17, 2020
A recent study examined what long-lasting effects cancer treatment has on long-term survivors. The researchers concluded ...
Rebecca AraujoOncology | April 13, 2023
Researchers Identify New Therapeutic Target for Prostate Cancer Treatment Resistance ...
Rebecca AraujoOncology | April 13, 2023
According to data from a new study, adolescent and young adult (AYA) patients who were treated for acute myeloid ...
Rebecca AraujoOncology | November 10, 2020
Prostate cancer cells with a deletion of the SUCLA2 gene are linked to treatment resistance and metastasis but can be ...
Advertisement
Advertisement
Advertisement
Latest News

June 21, 2024